Skip to main content
. Author manuscript; available in PMC: 2009 Sep 28.
Published in final edited form as: Invest Ophthalmol Vis Sci. 2009 May 14;50(8):3778–3782. doi: 10.1167/iovs.08-3264

FIGURE 4.

FIGURE 4

Soluble DAF treatment prevented mice from retinal injury in EAU. (A) Representative histology of ocular sections from soluble recombinant mouse DAF protein–treated mice and PBS-treated mice (n = 5 in each group). The eyes were sectioned on day 14 and stained with H&E. (B) ELISPOT assays of Th1 and Th17 responses in recombinant (light gray) DAF protein– and (dark gray) PBS-treated mice. Spleens were collected the same day mice were killed for ocular histology. Spleen cells (6 × 105/well) were assayed for the numbers of IFN-γ (Th1)– and IL-17 (Th17)–producing cells in response to different concentrations of IRBP161–180. *P < 0.05.